MKGAY Stock UPDATES Merck Kgaa Unsp ADR (MKGAY) 31.2300 09/24/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Merck Kgaa Unsp ADR (MKGAY) 31.2300 $MKGAY

European Stocks Trade Mixed as Confidence in Germany Drops
at The Street - 2 hrs ago
European stock markets are mixed as a drop in German business confidence stokes new concerns about the pace of economic recovery in Europe.

Ryan & Maniskas, LLP Announces Investigation of Sigma-Aldrich Corporation
PR Newswire - Tue Sep 23, 9:45AM CDT
Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Sigma-Aldrich Corporation ("Sigma-Aldrich" or the "Company" (NASDAQ: SIAL) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to Merck KGaA in a transaction valued at approximately $17 billion.

Polycystic Ovarian Syndrome Therapeutics Pipeline Review 2014 - 6 Companies & 9 Drug Profiles
M2 - Tue Sep 23, 9:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/sgjg9w/polycystic) has announced the addition of the "Polycystic Ovarian Syndrome - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Polycystic Ovarian Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Polycystic Ovarian Syndrome and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - AstraZeneca PLC - Euroscreen S.A. - Neurocrine Biosciences, Inc. - Merck KGaA - EffRx Pharmaceuticals S.A. - Crinetics Pharmaceuticals, Inc. Drug Profiles - choriogonadotropin alfa - AZD-4901 - ESN-364 - Small Molecule to Antagonize GnRH for Endometriosis, Uterine Fibroids, and Oncology - metformin hydrochloride - Synthetic Peptide to Target GPR54 for Womens Health, Male Health and Oncology - Synthetic Peptide for Metabolic Syndrome and Polycystic Ovarian Syndrome - Small Molecules to Inhibit KISS-1R For Polycystic Ovarian Syndrome - Small Molecules to Inhibit PAI-1 for Thromboembolic Disease, PCOS and Alopecia For more information visit http://www.researchandmarkets.com/research/sgjg9w/polycystic

SIGMA-ALDRICH INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sigma-Aldrich Corporation
PR Newswire - Mon Sep 22, 5:58PM CDT
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF" are investigating the proposed sale of Sigma-Aldrich Corporation ("Sigma-Aldrich" or the "Company" (NASDAQ: SIAL) to Merck KGaA. Under the terms of the proposed transaction, shareholders of Sigma-Aldrich will receive only $140 in cash for each share of Sigma-Aldrich common stock that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

Business Highlights
By The Associated Press - AP - Mon Sep 22, 5:00PM CDT
___

EQUITY ALERT: Rosen Law Firm Announces Investigation of Sigma-Aldrich Corporation Concerning its Proposed Sale to Merck KGaA
Business Wire - Mon Sep 22, 3:01PM CDT
The Rosen Law Firm, P.A. announces that it is investigating the Board of Directors of Sigma-Aldrich Corporation (NASDAQ:SIAL) for possible breaches of fiduciary duty and other violations of state law by failing to adequately shop Sigma-Aldrich to maximize shareholder value before agreeing to be acquired by Merck KGaA.

SIGMA-ALDRICH INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Sigma-Aldrich Corp. Over the Proposed Sale of the Company to Merck KGaA - SIAL
PR Newswire - Mon Sep 22, 12:08PM CDT
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Sigma-Aldrich Corp. ("Sigma-Aldrich" or the "Company" (Nasdaq: SIAL) for potential breaches of fiduciary duties in connection with the sale of the Company to Merck KGaA ("Merck" for approximately $17 billion. The Company's stockholders will receive $140 for each share of Sigma-Aldrich common stock they own.

SIGMA-ALDRICH SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Merck KGaA
Business Wire - Mon Sep 22, 10:27AM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Sigma-Aldrich Corporation ("Sigma-Aldrich" (NasdaqGS: SIAL) concerning the sale to Merck KGaA. Under the terms of the agreement, valued at approximately $17 billion, Sigma-Aldrich shareholders will only receive $140 in cash per share owned.

Block & Leviton LLP Investigates Sigma-Aldrich Corporation for Possible Breaches of Fiduciary Duty in Connection with Its Merger with Merck KGaA
PR Newswire - Mon Sep 22, 8:51AM CDT
Block & Leviton LLP (www.blockesq.com), a Boston-based law firm representing investors nationwide, has commenced an investigation into possible breaches of fiduciary duty by the Board of Directors of Sigma-Aldrich Corporation ("Sigma-Aldrich" or the "Company" (NASDAQ: SIAL) concerning its proposed merger with Merck KGaA ("Merck" .

German Merck to buy St. Louis-based Sigma-Aldrich
By DAVID McHUGH - AP - Mon Sep 22, 8:03AM CDT
FRANKFURT, Germany (AP) — German drug company Merck says it has agreed to buy St. Louis-based chemical firm Sigma-Aldrich Corp. for $17 billion in a deal Merck says will strengthen its business in chemicals and laboratory equipment.

EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time
CNW Group - Fri Sep 19, 3:10AM CDT
EMD Serono, a subsidiary of Merck KGaA, Darmstadt, Germany, today announced the first recipients of the Grant for Growth Innovation (GGI) for 2014. The awards were announced during a Satellite Symposium organized by EMD Serono at the 53rd European Society for Paediatric Endocrinology (ESPE) Meeting currently taking place in Dublin, Ireland.

Merck KGaA Strengthens Executive Board
CNW Group - Thu Sep 18, 10:39AM CDT
Merck KGaA today announced that the Board of Partners has promoted Stefan Oschmann (57) to the position of Deputy CEO and Vice Chairman of the Executive Board. Concurrently, Belén Garijo (54) was appointed to the Executive Board to take over leadership for the Pharma business. The management changes will become effective as of January 1, 2015.

EMD Serono and Sutro Biopharma to Partner on Development of Antibody Drug Conjugates
Business Wire - Wed Sep 17, 7:01AM CDT
--Sutro's Xpress CF and Xpress CF+ platforms to be utilized to develop antibody drug conjugates for multiple undisclosed targets

Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates
PR Newswire - Wed Sep 17, 7:00AM CDT
Sutro Biopharma, a biopharmaceutical company developing antibody drug conjugates and bispecific antibodies, and the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the United States and Canada, today announced a collaboration and license agreement to develop antibody drug conjugates (ADCs). ADCs are composed of an antibody linked to a cytotoxic drug. The antibody is thought to specifically target and deliver the cytotoxic drug to the cancer cells.

The Zacks Analyst Blog Highlights: Merck KGaA, Lannett, Avanir Pharmaceuticals, Anacor Pharmaceuticals and Helen of Troy
PR Newswire - Tue Sep 16, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Merck KGaA (OTC:MKGAF-Free Report), Lannett Company, Inc. (NYSE:LCI-Free Report), Avanir Pharmaceuticals, Inc. (Nasdaq:AVNR-Free Report), Anacor Pharmaceuticals, Inc. (Nasdaq:ANAC-Free Report) and Helen of Troy Limited (Nasdaq:HELE-Free Report).

EMD Millipore Recognized for Technologically Advanced Products by R&D Magazine
Business Wire - Mon Sep 15, 7:00AM CDT
EMD Millipore, the Life Science division of Merck KGaA, announced it has received two R&D Magazine 100 Awards for innovative products released to market in 2014. The 52nd Annual R&D Awards recognize the 100 most technologically significant products introduced into the marketplace over the past year.

Merck KGaA Discontinues Clinical Development Program of Tecemotide as a Monotherapy in Stage III Non-Small Cell Lung Cancer
CNW Group - Fri Sep 12, 9:54AM CDT
Merck KGaA, Darmstadt, Germany, announced today that its biopharmaceutical division will discontinue the clinical development program of its investigational MUC1 antigen-specific cancer immunotherapy tecemotide (also known as L-BLP25) as a monotherapy in Stage III non-small cell lung cancer (NSCLC).

EMD Serono Honors Recipients of the Second Annual EUR 1 Million Grant for Multiple Sclerosis Innovation
PR Newswire - Fri Sep 12, 7:00AM CDT
EMD Serono Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, today announced the recipients of the second annual Grant for Multiple Sclerosis Innovation (GMSI) at the 2014 Joint ACTRIMS-ECTRIMS Meeting of the Americas Committee for Treatment and Research in MS (ACTRIMS) and European Committee for Treatment and Research in MS (ECTRIMS), taking place September 10-13, in Boston, U.S.A.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bill Targets 15% Federal Goal for Women-Owned Firms

Updated Category News Views 28

Federal procurement has a stubborn habit of sounding abstract until you remember that contracts can decide whether a small company hires, invests, or simply keeps the lights on. Senator Adam Schiff introduced the Women's Economic Fairness and Small Business Contracting Act on November 19, 2026, proposing to raise the federal goal for Women-Owned Small Businesses from 5%...

Continue Reading
Vizsla's Panuco Delay Puts Security Ahead of Speed

Updated Category News Views 110

A mine schedule can absorb a calendar slip; the people around a mine cannot be treated like a line item. Vizsla Silver's update on Panuco is therefore not the usual development-company chest thumping. It is a sober admission that security, permitting and site readiness have pushed first silver to the second half of 2028, one year later than the prior H2 2027 target....

Continue Reading
Lowe's Dec. 9 Conference Puts Strategy on the Clock

Updated Category News Views 0

A Calendar Entry With Real Weight December 9 is not earnings day, but it is the sort of date shareholders ought to circle anyway. Lowe's plans to hold its 2026 Analyst and Investor Conference at 8 a.m. Eastern time in New York City, with a live webcast available for those not sitting in the room. For owners of NYSE:LOW, these gatherings can be more useful than the usual...

Continue Reading
Corner Bakery Bets on Holiday Catering Convenience

Updated Category News Views 51

A $50 carrot on a $350 catering tab tells you exactly where Corner Bakery sees the holiday battlefield: not in one lonely cookie sale, but in the larger group order that can make a restaurant’s day. The chain is pushing holiday catering through November and December, pairing that discount with bakery trays, meals for groups and a promise to handle delivery setup. It is...

Continue Reading
A Quanzhou Table Offers China Beyond the Headlines

Updated Category News Views 150

Steam rising from a Quanzhou table can carry more weight than another polished speech about cultural exchange. That is the sensible instinct behind Home Banquets with Master Chefs, the CCTV-4 series using regional meals to explore geography, customs and memory. It is not trying to explain China through a pile of statistics or a museum-label summary. It starts where people...

Continue Reading
Receipts Turns Vegas Party Shirts Into AR Keepsakes

Updated Category News Views 118

A shirt that coughs up a Vegas weekend when scanned is either a smart little keepsake trick or a privacy headache wearing sequins. Receipts™, introduced by Las Vegas-based Naked City Couture and the AR Trading Card Company, is betting it can be the former. The concept is simple enough: friends wear the apparel, capture photos and videos during a trip, upload those...

Continue Reading
PARRIS Partners Earn 2026 Plaintiff Lawyer Recognition

Updated Category News Views 95

A $58.4 million jury number can make a courtroom sound like a slot machine, until the final settlement lands at $21 million. That gap is the part people ought to stare at before getting carried away by another plaintiff-lawyer honor roll. The Daily Journal has named PARRIS Law Firm partners Alexander R. Wheeler and Khail A. Parris to its 2026 Top Plaintiff Lawyers special...

Continue Reading
Yiwu Squishies Turn Viral Demand Into Factory Backlogs Worldwide

Updated Category News Views 55

A pizza-shaped stress toy booking more than one million units is the sort of detail that makes a jaded market watcher sit up before rolling his eyes at the word “viral.” Yiwu’s squishy-toy surge appears to have moved beyond a few social-media impulses and into actual factory scheduling, repeat purchase orders and supermarket procurement. That is meaningful. It is...

Continue Reading
Cirrus CEO Takes SIA Chair as Chip Policy Heats Up

Updated Category News Views 17

A trade-group gavel rarely moves a stock by itself, but this one lands in a noisy part of the chip cycle. On November 19, 2026, the Semiconductor Industry Association elected Cirrus Logic President and CEO John Forsyth as chair of its board. That is not a revenue announcement, not a factory groundbreaking, and certainly not a reason to start flinging confetti at...

Continue Reading
ROHM's GaN PFC Chip Targets the Power-Supply Squeeze

Updated Category News Views 118

Power supplies are where a lot of sleek electronics quietly lose the plot, and ROHM is taking a proper swing at that problem. Its new BM85060FV is a totem-pole power factor correction controller built for gallium nitride, or GaN, high-frequency switching in AC-DC power supplies. The headline is not subtle: ROHM says a 300 to 500 W system using the chip can reach 99%...

Continue Reading

Top 5 Most Recently Viewed Articles

Addgene Launches Innovative Antibody Characterization Platform

Updated Category News Views 109

Addgene Launches Innovative Antibody Characterization Platform Addgene, a visionary organization dedicated to enhancing scientific research, recently introduced a groundbreaking antibody characterization platform that draws from its extensive antibody catalog. This initiative aims to significantly advance the field of biomedical research by ensuring that antibodies are...

Continue Reading
Nishant Saxena Joins Jeune Aesthetics as CFO to Drive Growth

Updated Category News Views 294

Jeune Aesthetics Welcomes New Chief Financial Officer Jeune Aesthetics has taken a significant step forward by appointing Nishant Saxena as its Chief Financial Officer (CFO). This decision comes at a crucial time as the company prepares to advance its growth strategies and innovate in the field of medical aesthetics designed to combat aging skin. Understanding the...

Continue Reading
Organ Preservation Solutions Market to Reach $512.62 Million by 2031

Updated Category News Views 144

Growth of the Organ Preservation Solutions Market The organ preservation solutions market is experiencing significant growth as the global demand for organ transplantation rises. According to a comprehensive report from The Insight Partners, it is projected that this market will reach a remarkable $512.62 million by 2031 with a compound annual growth rate (CAGR) of 8.1%....

Continue Reading
Alpine Income Property Trust Secures $14.1 Million Mortgage Loan

Updated Category News Views 133

Alpine Income Property Trust Makes Strategic Mortgage Investment WINTER PARK, Fla. – Alpine Income Property Trust, Inc. (NYSE: PINE), a well-known real estate investment trust, has recently announced a significant investment by originating a first mortgage loan. The loan investment, amounting to $14.1 million, is secured by a luxury residential development featuring...

Continue Reading
Zenity Introduces New Framework for Securing GenAI Systems

Updated Category News Views 127

Zenity Introduces GenAI Attacks Matrix for Enhanced Security Zenity, a leader in the security domain for enterprise copilots and low-code development, has launched its innovative security framework known as the GenAI Attacks Matrix. This open-source initiative is inspired by the renowned MITRE ATLAS and developed with contributions from top security researchers worldwide,...

Continue Reading